| Financial Year |
March 31 2023 |
| Monetary Funds |
212,933,561.57 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
309,150,545.27 |
| Advances to Suppliers |
24,112,576.64 |
| Other Receivables |
232,792,971.90 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
121,774,300.75 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
21,348,640.96 |
| Total Current Assets |
970,358,750.07 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
5,495,695.64 |
| Fixed Assetes |
537,364,024.97 |
| Under-construction Projects |
361,961,108.48 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
37,103,584.21 |
| R&D expenses |
-- |
| Goodwill |
27,187,517.14 |
| Long-Term Deferred and Prepaid Expenses |
5,570,938.48 |
| Deferred Income Tax Assets |
18,635,298.38 |
| Other Non-Current Assets |
949,500.00 |
| Sub-Total of Non-Current Assets |
1,048,048,412.01 |
| Total Assets |
2,018,407,162.08 |
| Short-Term Loans |
307,372,305.55 |
| Trading Financial liabilities |
-- |
| Notes Payable |
14,134,277.58 |
| Accounts Payable |
86,248,580.43 |
| Accounts Received In Advance |
43,894.85 |
| Employee Compensation Payable |
6,501,220.87 |
| Taxes Payable |
6,432,806.08 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
9,282,058.30 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
11,365,787.68 |
| Other Current Liabilities |
1,328,523.79 |
| Sub-Total of Current Liabilities |
452,929,636.38 |
| Long-term Loans |
71,633,846.16 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
6,314,771.35 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
126,521,969.95 |
| Total Liabilities |
579,451,606.33 |
| Paid-In Capital(Or Share Stock) |
144,790,322.00 |
| Capital Surplus |
680,765,027.86 |
| Surplus Reserve |
60,990,520.77 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
539,298,395.34 |
| Minority Stockholder's Interest |
13,111,289.78 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,425,844,265.97 |
| Owner's Equity（Stockholder's Equity） |
1,438,955,555.75 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,018,407,162.08 |
